BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19015833)

  • 1. Discreplasminin, a plasmin inhibitor isolated from Tityus discrepans scorpion venom.
    Brazón J; D'Suze G; D'Errico ML; Arocha-Piñango CL; Guerrero B
    Arch Toxicol; 2009 Jul; 83(7):669-78. PubMed ID: 19015833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin(ogen)olytic enzymes in scorpion (Tityus discrepans) venom.
    Brazón J; Guerrero B; D'Suze G; Sevcik C; Arocha-Piñango CL
    Comp Biochem Physiol B Biochem Mol Biol; 2014 Feb; 168():62-9. PubMed ID: 24291691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
    Cheng AC; Tsai IH
    Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of tenerplasminin-1, a serine peptidase inhibitor with antiplasmin activity from the coral snake (Micrurus tener tener) venom.
    Vivas J; Ibarra C; Salazar AM; Neves-Ferreira AG; Sánchez EE; Perales J; Rodríguez-Acosta A; Guerrero B
    Comp Biochem Physiol C Toxicol Pharmacol; 2016 Jan; 179():107-15. PubMed ID: 26419785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
    Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
    Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrinolytic role of a bee venom serine protease inhibitor that acts as a plasmin inhibitor.
    Choo YM; Lee KS; Yoon HJ; Qiu Y; Wan H; Sohn MR; Sohn HD; Jin BR
    PLoS One; 2012; 7(2):e32269. PubMed ID: 22359676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpesviruses enhance fibrin clot lysis.
    Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
    Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents.
    Flight S; Johnson L; Trabi M; Gaffney P; Lavin M; de Jersey J; Masci P
    Pathophysiol Haemost Thromb; 2005; 34(4-5):188-93. PubMed ID: 16707925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
    Weisdorf DJ; Aldridge JH
    Thromb Haemost; 1988 Jun; 59(3):440-4. PubMed ID: 2973151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new Kunitz-type plasmin inhibitor from scorpion venom.
    Ding L; Wang X; Liu H; San M; Xu Y; Li J; Li S; Cao Z; Li W; Wu Y; Chen Z
    Toxicon; 2015 Nov; 106():7-13. PubMed ID: 26363290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraction of plasminogen activator in the rat's submaxillary gland.
    Lucas ON; Lucas GV
    Acta Physiol Pharmacol Ther Latinoam; 1995; 45(2):115-22. PubMed ID: 8580523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of Tityus discrepans scorpion venom and amino acid sequence of novel toxins.
    Batista CV; D'Suze G; Gómez-Lagunas F; Zamudio FZ; Encarnación S; Sevcik C; Possani LD
    Proteomics; 2006 Jun; 6(12):3718-27. PubMed ID: 16705749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of homocysteine on fibrin network lysis.
    Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
    de Haan J; van Oeveren W
    Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: identification as immunoglobulin kappa light chain.
    Boivin D; Provençal M; Gendron S; Ratel D; Demeule M; Gingras D; Béliveau R
    Arch Biochem Biophys; 2004 Nov; 431(2):197-206. PubMed ID: 15488468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.